211 related articles for article (PubMed ID: 31499501)
21. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
Kostakis EK; Gkioni LN; Macut D; Mastorakos G
Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
[TBL] [Abstract][Full Text] [Related]
22. Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years.
Carmina E; Longo RA
Cells; 2022 Oct; 11(20):. PubMed ID: 36291122
[TBL] [Abstract][Full Text] [Related]
23. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
Rosenfield RL; Mortensen M; Wroblewski K; Littlejohn E; Ehrmann DA
Hum Reprod; 2011 Nov; 26(11):3138-46. PubMed ID: 21908468
[TBL] [Abstract][Full Text] [Related]
24. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
25. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
26. Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
Braun LT; Osswald A; Zopp S; Rubinstein G; Vogel F; Riester A; Honegger J; Eisenhofer G; Constantinescu G; Deutschbein T; Quinkler M; Elbelt U; Künzel H; Nowotny HF; Reisch N; Hartmann MF; Beuschlein F; Pons-Kühnemann J; Reincke M; Wudy SA
EBioMedicine; 2024 Jan; 99():104907. PubMed ID: 38128413
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
28. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
29. Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome.
Gourgari E; Lodish M; Keil M; Sinaii N; Turkbey E; Lyssikatos C; Nesterova M; de la Luz Sierra M; Xekouki P; Khurana D; Ten S; Dobs A; Stratakis CA
J Clin Endocrinol Metab; 2016 Sep; 101(9):3353-60. PubMed ID: 27336356
[TBL] [Abstract][Full Text] [Related]
30. Approach to androgen excess in women: Clinical and biochemical insights.
Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
[TBL] [Abstract][Full Text] [Related]
31. The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome.
Carmina E; Gonzalez F; Vidali A; Stanczyk FZ; Ferin M; Lobo RA
Hum Reprod; 1999 Feb; 14(2):307-11. PubMed ID: 10099969
[TBL] [Abstract][Full Text] [Related]
32. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW
J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266
[TBL] [Abstract][Full Text] [Related]
33. High androgen concentrations in follicular fluid of polycystic ovary syndrome women.
Bongrani A; Plotton I; Mellouk N; Ramé C; Guerif F; Froment P; Dupont J
Reprod Biol Endocrinol; 2022 Jun; 20(1):88. PubMed ID: 35701786
[TBL] [Abstract][Full Text] [Related]
34. Recurrent Cushing's disease with low adrenal androgen production.
Louard RJ; Gelfand RA
J Endocrinol Invest; 1991 Dec; 14(11):965-9. PubMed ID: 1666899
[TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of adrenal and extra adrenal hyperandrogenism.
McKenna TJ; Cunningham SK
J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):117-21. PubMed ID: 8481335
[TBL] [Abstract][Full Text] [Related]
36. Serum steroid profiling in Cushing's syndrome patients.
Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
J Steroid Biochem Mol Biol; 2019 Sep; 192():105410. PubMed ID: 31201926
[TBL] [Abstract][Full Text] [Related]
37. Pitfalls in the diagnosis and management of Cushing's syndrome.
Bansal V; El Asmar N; Selman WR; Arafah BM
Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiology and diagnosis of Cushing's syndrome.
Miyachi Y
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():113s-117s. PubMed ID: 10915006
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea.
Yilmaz H; Demirpence M; Belet U; Ozkiliç I; Colak A; Ceylan S; Sarıkaya M; Yasar E
Endokrynol Pol; 2024; 75(1):89-94. PubMed ID: 38497394
[TBL] [Abstract][Full Text] [Related]
40. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
